Face Perception vs. Memory Training to Improve Face Recognition in Developmental Prosopagnosia

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Developmental Prosopagnosia

In brief

The goal of this study is to test the effectiveness of two experimental training programs aimed at improving face processing in developmental prosopagnosia (perception training, memory training) in comparison to an active control. The investigators will use a longitudinal design and randomize developmental prosopagnosics to three parallel arms: active control, perception training and memory training.

Key facts

Study ID

NCT05800782

Run by

Boston VA Research Institute, Inc.

People needed

72

Starts

2023-10-15

Expected to finish

2025-02-21

Last updated by the study team

2024-01-12

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18-90
• Have lifelong histories of face recognition difficulties that impact everyday life (i.e., not associated with some event such as a stroke, seizure, etc)
• Score > 2 standard deviations below the mean on the famous faces test and Cambridge Face Memory Test. This is in line with our previous studies and others in the literature.

You may not qualify if…

• History of a significant neurological disorder including hydrocephalus, stroke, moderate to severe traumatic brain injury (TBI), severe neuromuscular diseases, or severe hypoxia due to cardiac arrest.
• Participants with a history of mild TBI or simple concussion will not be excluded as long as it was > 6 months ago and as long as they have not had repeated concussions (>5).
• Participants will be excluded if they have impairments that interfere with cognitive performance, such as uncorrected hearing or vision, lack of English proficiency, musculoskeletal or other issues.
• Additionally, participants will be excluded if they have psychiatric disorders, such as schizophrenia, major depressive disorder, bipolar disorder, chronic intractable obsessive-compulsive disorder, or agoraphobia.
• Participants with a diagnosis of ADHD will be included as long as their medication has been consistent for the past 6 months.
• Participants who are currently dependent on alcohol or other substances will be excluded, as this may negatively impact cognitive performance.
• Participants who currently are, or within the last 6 months, participating in a behavioral or pharmacological intervention will be excluded.

Where it is running

• VA Boston Healthcare System — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.